Moreover, haspin elimination by CRISPR sensitizes tumor cells to VX680, an Aurora kinase B inhibitor in head and neck squamous cell carcinomas (HNSCC) and non-small cell lung cancer (NSCLC) cell lines [149]. Here, AURKB is linked to head and neck squamous cell carcinoma.